How COVID-19 interacts with interstitial lung disease
Open Access
- 7 March 2022
- journal article
- review article
- Published by European Respiratory Society (ERS) in Breathe
- Vol. 18 (1) , 210158
Abstract
The global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had far-reaching impacts on patients with interstitial lung disease (ILD), from diagnosis to management. In addition, after infection, persistent parenchymal change is associated with ongoing symptoms and functional impairment even in patients without pre-existing lung disease. The challenge of investigating and treating these patients has often fallen to ILD physicians. This review therefore seeks to explore the relationship between COVID-19 and the interstitium, as well as the model of care for patients with pre-existing ILD and those patients with persistent disease following recovery from their initial infection.Educational aims: To understand the impact of the COVID-19 pandemic on patients with existing interstitial lung disease. To explore the development of interstitial lung disease after COVID-19 infection.Keywords
This publication has 39 references indexed in Scilit:
- Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 PandemicChest, 2020
- Telemedicine in the Era of COVID-19The Journal of Allergy and Clinical Immunology: In Practice, 2020
- Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort studyBone Research, 2020
- Effect of ambulatory oxygen on quality of life for patients with fibrotic lung disease (AmbOx): a prospective, open-label, mixed-method, crossover randomised controlled trialThe Lancet Respiratory Medicine, 2018
- Daily Home Spirometry: An Effective Tool for Detecting Progression in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2016
- Thin-Section Computed Tomography Manifestations During Convalescence and Long-Term Follow-Up of Patients with Severe Acute Respiratory Syndrome (SARS)Medical Science Monitor, 2016
- Radiologic Outcomes at 5 Years After Severe ARDSChest, 2013
- The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significanceEuropean Respiratory Journal, 2013
- Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivorsThorax, 2005
- Six month radiological and physiological outcomes in severe acute respiratory syndrome (SARS) survivorsThorax, 2004